Likewise, while Witjes et al. [16] achieved an AUC of 0.94 using methylation panels, these models lacked adjustment for tumor immune contexture or metabolic biomarkers like CYP4Z1/CYP1B1 (Al-Saraireh et al. [17]). This evidence concerns the gene CYP1B1 and neoplasm.